Anticancer drug discovery through genome-scale metabolic modeling

Altered metabolism has long been recognized as a defining property of cancer physiology, but is experiencing renewed interest as the importance of such alterations are becoming fully realized. Once regarded merely as a side effect of a damaging mutation or a general increase in proliferation rate, metabolic network rewiring is now viewed as an intentional process to optimize tumor growth and maintenance, and can even drive cancer transformation. This has motivated the search for anticancer targets among enzymes in the metabolic network of cancer cells. Genome-scale metabolic models (GEMs) provide the necessary framework to systematically interrogate this network, and many recent studies have successfully employed GEMs to predict anticancer drug targets in the metabolic networks of various cancer types.

[1]  P. Ward,et al.  Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. , 2012, Cancer cell.

[2]  C. Thompson,et al.  The Emerging Hallmarks of Cancer Metabolism. , 2016, Cell metabolism.

[3]  Jaeyun Sung,et al.  Molecular signatures from omics data: From chaos to consensus , 2012, Biotechnology journal.

[4]  Matej Oresic,et al.  Integrated Systems and Technologies Metabolic Associations of Reduced Proliferation and Oxidative Stress in Advanced Breast Cancer , 2012 .

[5]  V. Mootha,et al.  Metabolic enzyme expression highlights a key role for MTHFD2 and the mitochondrial folate pathway in cancer , 2014, Nature Communications.

[6]  M. Uhlén,et al.  Genome-scale metabolic modelling of hepatocytes reveals serine deficiency in patients with non-alcoholic fatty liver disease , 2014, Nature Communications.

[7]  Jae Yong Ryu,et al.  Reconstruction of genome-scale human metabolic models using omics data. , 2015, Integrative biology : quantitative biosciences from nano to macro.

[8]  O. Feron,et al.  Challenges and Opportunities in the Development of Serine Synthetic Pathway Inhibitors for Cancer Therapy. , 2017, Journal of medicinal chemistry.

[9]  C. Thompson,et al.  Glutamine addiction: a new therapeutic target in cancer. , 2010, Trends in biochemical sciences.

[10]  Karen H. Vousden,et al.  Serine and one-carbon metabolism in cancer , 2016, Nature Reviews Cancer.

[11]  I. Nookaew,et al.  Integration of clinical data with a genome-scale metabolic model of the human adipocyte , 2013, Molecular systems biology.

[12]  N. McGranahan,et al.  Biological and therapeutic impact of intratumor heterogeneity in cancer evolution. , 2015, Cancer cell.

[13]  Edward J. O'Brien,et al.  Using Genome-scale Models to Predict Biological Capabilities , 2015, Cell.

[14]  Aarash Bordbar,et al.  Systems biology analysis of drivers underlying hallmarks of cancer cell metabolism , 2017, Scientific Reports.

[15]  Ronan M. T. Fleming,et al.  A community-driven global reconstruction of human metabolism , 2013, Nature Biotechnology.

[16]  Eytan Ruppin,et al.  Modeling cancer metabolism on a genome scale , 2015, Molecular systems biology.

[17]  Monica L. Mo,et al.  Global reconstruction of the human metabolic network based on genomic and bibliomic data , 2007, Proceedings of the National Academy of Sciences.

[18]  R. Hertz,et al.  Effect of Methotrexate Therapy upon Choriocarcinoma and Chorioadenoma , 1956, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[19]  L. Cantley,et al.  Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.

[20]  G. von Heijne,et al.  Tissue-based map of the human proteome , 2015, Science.

[21]  V. Siewers,et al.  Production of fatty acid-derived oleochemicals and biofuels by synthetic yeast cell factories , 2016, Nature Communications.

[22]  D. Sabatini,et al.  Cancer cell metabolism: one hallmark, many faces. , 2012, Cancer discovery.

[23]  C. Gille,et al.  HepatoNet1: a comprehensive metabolic reconstruction of the human hepatocyte for the analysis of liver physiology , 2010, Molecular systems biology.

[24]  Jens Nielsen,et al.  Flux balance analysis predicts essential genes in clear cell renal cell carcinoma metabolism , 2015, Scientific Reports.

[25]  Nathan C. Sheffield,et al.  Multi-Omics of Single Cells: Strategies and Applications , 2016, Trends in biotechnology.

[26]  Alexander van Oudenaarden,et al.  Spatially resolved transcriptomics and beyond , 2014, Nature Reviews Genetics.

[27]  I. Nookaew,et al.  Glycosaminoglycan Profiling in Patients' Plasma and Urine Predicts the Occurrence of Metastatic Clear Cell Renal Cell Carcinoma. , 2016, Cell reports.

[28]  M. Cascante,et al.  Cancer cell metabolism as new targets for novel designed therapies. , 2014, Future medicinal chemistry.

[29]  A. Schulze,et al.  Systematic Analysis Reveals that Cancer Mutations Converge on Deregulated Metabolism of Arachidonate and Xenobiotics. , 2016, Cell reports.

[30]  K. Polyak,et al.  Tumor heterogeneity: causes and consequences. , 2010, Biochimica et biophysica acta.

[31]  Donald Geman,et al.  Identifying Tightly Regulated and Variably Expressed Networks by Differential Rank Conservation (DIRAC) , 2010, PLoS Comput. Biol..

[32]  Marco Fondi,et al.  Comparative genome-scale modelling of Staphylococcus aureus strains identifies strain-specific metabolic capabilities linked to pathogenicity , 2016, Proceedings of the National Academy of Sciences.

[33]  Nathan E. Lewis,et al.  The evolution of genome-scale models of cancer metabolism , 2013, Front. Physiol..

[34]  Jens Nielsen,et al.  New paradigms for metabolic modeling of human cells. , 2015, Current opinion in biotechnology.

[35]  J. Nielsen,et al.  Cancer Metabolism: A Modeling Perspective , 2015, Front. Physiol..

[36]  Natapol Pornputtapong,et al.  Reconstruction of Genome-Scale Active Metabolic Networks for 69 Human Cell Types and 16 Cancer Types Using INIT , 2012, PLoS Comput. Biol..

[37]  Gabriela Kalna,et al.  Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase , 2011, Nature.

[38]  J. Borén,et al.  Personalized Cardiovascular Disease Prediction and Treatment—A Review of Existing Strategies and Novel Systems Medicine Tools , 2016, Front. Physiol..

[39]  Matthew G. Vander Heiden,et al.  Metabolic targets for cancer therapy , 2013, Nature Reviews Drug Discovery.

[40]  J. Nielsen,et al.  Identification of anticancer drugs for hepatocellular carcinoma through personalized genome‐scale metabolic modeling , 2014, Molecular systems biology.

[41]  T. Shlomi,et al.  Quantitative flux analysis reveals folate-dependent NADPH production , 2014, Nature.

[42]  Jens Nielsen,et al.  Logical transformation of genome-scale metabolic models for gene level applications and analysis , 2015, Bioinform..

[43]  Jens Nielsen,et al.  Systems Biology of Metabolism: A Driver for Developing Personalized and Precision Medicine. , 2017, Cell metabolism.

[44]  Eytan Ruppin,et al.  Phenotype-based cell-specific metabolic modeling reveals metabolic liabilities of cancer , 2014, eLife.

[45]  I. Nookaew,et al.  Chromosome 3p loss of heterozygosity is associated with a unique metabolic network in clear cell renal carcinoma , 2014, Proceedings of the National Academy of Sciences.

[46]  Zachary A. King,et al.  Constraint-based models predict metabolic and associated cellular functions , 2014, Nature Reviews Genetics.

[47]  B. Palsson,et al.  A protocol for generating a high-quality genome-scale metabolic reconstruction , 2010 .

[48]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[49]  Eytan Ruppin,et al.  A computational study of the Warburg effect identifies metabolic targets inhibiting cancer migration , 2014, Molecular Systems Biology.

[50]  E. Gottlieb,et al.  Targeting metabolic transformation for cancer therapy , 2010, Nature Reviews Cancer.

[51]  Jeffrey D Orth,et al.  What is flux balance analysis? , 2010, Nature Biotechnology.

[52]  J. Locasale,et al.  The Warburg Effect: How Does it Benefit Cancer Cells? , 2016, Trends in biochemical sciences.

[53]  J. Nielsen,et al.  Stratification of Hepatocellular Carcinoma Patients Based on Acetate Utilization. , 2015, Cell reports.

[54]  H. Eagle,et al.  Nutrition needs of mammalian cells in tissue culture. , 1955, Science.

[55]  Avlant Nilsson,et al.  Genome scale metabolic modeling of cancer. , 2017, Metabolic engineering.

[56]  Jonathan L. Robinson,et al.  Integrative analysis of human omics data using biomolecular networks. , 2016, Molecular bioSystems.

[57]  E. Ruppin,et al.  Predicting Drug Targets and Biomarkers of Cancer via Genome-Scale Metabolic Modeling , 2012, Clinical Cancer Research.

[58]  Erwin P. Gianchandani,et al.  Predicting biological system objectives de novo from internal state measurements , 2008, BMC Bioinformatics.

[59]  M. V. Heiden,et al.  Targeting cancer metabolism: a therapeutic window opens , 2011, Nature Reviews Drug Discovery.

[60]  Bruce D Cheson,et al.  Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development , 2005, Clinical Cancer Research.

[61]  Mathias Uhlen,et al.  Identifying anti-growth factors for human cancer cell lines through genome-scale metabolic modeling , 2015, Scientific Reports.

[62]  O. Warburg.  [Origin of cancer cells]. , 1956, Oncologia.